Cyclo Therapeutics, Inc.
CYTHW
|
NASDAQ
|
0 Sledující
Company Quality
Profitability Score
33/100
Solvency Score
5/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Drug Manufacturers - Specialty & Generic
Průmysl
Mr. N. Scott Fine
CEO
8
Zaměstnanci
Gainesville
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$24MEnterprise Value
$35MPrice to Earnings
-0.83Price to Sales
27.09Price to Book
-1.54Price to Cash Flow
-0.89Profitability
Return on Assets
-472.02%Return on Equity
749.85%Return on Invested Capital
1,946.00%Gross Margin
-205.60%Operating Margin
-2,834.06%Net Margin
-2,848.16%Liquidity
Quick Ratio
0.16Current Ratio
0.17Cash Ratio
0.05Inventory Turnover
11.27Asset Turnover
0.17Total Liabilities
$19MSolvency
Debt to Assets
2.32Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
-2.56Long-term Debt to Cap.
0.00Altman Z-Score
-46.29Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.